Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chromosome changes in the lymphomas

A A Sandberg

    Human Pathology
    |June 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Chromosomal abnormalities, including the 14q+ marker, are common in lymphomas. While t(8;14) is typical for Burkitt

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cytogenetic and pathologic aspects of Ewing's sarcoma and neuroectodermal tumors.

    Human pathology·1992
    Same author

    Translocation (X;1)(p11.2;q21). A subtype of renal adenocarcinomas.

    Cancer genetics and cytogenetics·1992
    Same author

    Cytogenetic and molecular studies of a familial renal cell carcinoma.

    Cancer genetics and cytogenetics·1992
    Same author

    Cytogenetic and fluorescence in situ hybridization analysis of breast fibroadenomas.

    Cancer genetics and cytogenetics·1992
    Same author

    Application of fluorescence in situ hybridization in hematological disorders.

    Cancer genetics and cytogenetics·1992
    Same author

    Cytogenetic and FISH studies of abnormal X chromosomes in a patient with ANLL.

    Cancer genetics and cytogenetics·1992
    Same journal

    Prognostic relevance and molecular correlates of Claudin-1 expression in pancreatic neuroendocrine tumors.

    Human pathology·2026
    Same journal

    Mixed Phenotype Acute Leukemia: Lineage Assignment, Immunophenotypic Classification and Genetic Insights.

    Human pathology·2026
    Same journal

    Chronic myelomonocytic leukemia revisited: A comprehensive review with emphasis on the oligomonocytic subtype.

    Human pathology·2026
    Same journal

    Artificial intelligence-assisted screening for NTRK fusion-positive salivary gland tumors: A novel digital pathology workflow.

    Human pathology·2026
    Same journal

    Evaluation of prognostic factors and outcomes in primary versus secondary myeloid sarcoma.

    Human pathology·2026
    Same journal

    The Farooq, not the Lerner, grading system predicts disease-specific and overall survival in duodenal graft-versus-host disease.

    Human pathology·2026
    See all related articles

    Area of Science:

    • Cytogenetics
    • Hematology
    • Oncology

    Background:

    • A significant percentage of lymphomas exhibit a marker chromosome 14q+.
    • Historically, Burkitt's lymphoma was associated with the t(8;14)(q24;32) translocation.
    • Recent findings suggest 8q- may be a more specific marker for Burkitt's lymphoma than 14q+.

    Purpose of the Study:

    • To investigate the role of chromosomal abnormalities in lymphoma classification.
    • To explore the specificity of chromosomal translocations in Burkitt's and non-Burkitt's lymphomas.

    Main Methods:

    • Analysis of chromosomal translocations in lymphoma cases.
    • Comparison of translocation patterns between Burkitt's and non-Burkitt's lymphomas.

    Main Results:

    Related Experiment Videos

    • Translocations involving chromosome 8 with chromosomes 2 or 22 are observed in a notable number of Burkitt's lymphoma cases.
    • Chromosome 14 is frequently the recipient of translocated material in non-Burkitt's lymphomas, with various donor chromosomes identified (e.g., 1, 2, 4, 6, 10, 11, 14, 18).

    Conclusions:

    • The 8q- abnormality may be more characteristic of Burkitt's lymphoma than the 14q+ marker.
    • No established clinical specificity of donor chromosomes in non-Burkitt's lymphomas has been found to date.
    • Further data correlating chromosomal information with clinical and histological features is needed for precise non-Burkitt's lymphoma classification.